Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

TQB2450 Plus Anlotinib as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Resection

Xianhai Mao · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
hcchepatocellular-carcinoma
hepatocellular carcinoma, adjuvant therapy, hcc, tqb2450, anlotinib, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 875257
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.